Literature DB >> 19463309

A comparison of 2 thrombus aspiration devices with histopathological analysis of retrieved material in patients presenting with ST-segment elevation myocardial infarction.

Pieter J Vlaar1, Tone Svilaas, Mathijs Vogelzang, Gilles F Diercks, Bart J de Smet, Ad F van den Heuvel, Rutger L Anthonio, Gillian A Jessurun, Esjong Tan, Albert J Suurmeijer, Felix Zijlstra.   

Abstract

OBJECTIVES: The objective of this study was to compare 2 manual thrombus aspiration catheters in unselected patients with ST-segment elevation myocardial infarction.
BACKGROUND: Distal embolization is common during percutaneous coronary intervention in ST-segment elevation myocardial infarction and can induce impaired myocardial perfusion. Several aspiration thrombectomy devices have been introduced to prevent distal embolization, however, with conflicting clinical results. Currently, it is unclear to what extent this variance in outcome can be explained by device-related factors, such as internal lumen size.
METHODS: We performed a prospective cohort study in which patients undergoing primary percutaneous coronary intervention were treated with a large-internal-lumen catheter (Diver, Invatec, Roncadelle, Italy). Outcomes were compared with a matched population of the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS) trial, in which patients were treated with a medium-sized catheter (Export, Medtronic, Minneapolis, Minnesota). A histopathological analysis was performed of retrieved material.
RESULTS: A total of 160 patients, treated with the Diver (n = 80) or Export (n = 80) aspiration catheter, were enrolled. Effective thrombus aspiration was seen in 70.3% of the patients treated with the Diver catheter versus 81.8% with the Export catheter (p = 0.10) No significant difference was found in myocardial blush grade or electrocardiographic outcome between the 2 devices. Size distribution of retrieved thrombotic particles was similar per device. Erythrocyte-rich thrombi were found in 34.8% of the cases and were predominately seen in patients with low initial Thrombolysis In Myocardial Infarction flow grade (p = 0.008).
CONCLUSIONS: A larger internal lumen diameter does not result in retrieval of larger thrombotic particles, nor in improved angiographic or electrocardiographic outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 19463309     DOI: 10.1016/j.jcin.2008.03.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  7 in total

1.  Thrombus Aspiration in STEMI.

Authors:  Konstantinos Marmagkiolis; Dmitriy N Feldman; Konstantinos Charitakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-01

2.  Applicability and reproducibility of ELSHAFEY technique in different thrombus containing coronary lesions.

Authors:  Wassam El Din Hadad Elshafey
Journal:  Indian Heart J       Date:  2017-05-20

3.  Use of Thrombectomy Devices in Primary Percutaneous Interventions for ST-elevation Myocardial Infarction - An Update.

Authors:  Krishnaraj S Rathod; Stephen M Hamshere; Tawfiq R Choudhury; Daniel A Jones; Anthony Mathur
Journal:  Interv Cardiol       Date:  2014-04

Review 4.  Thrombus aspiration in acute myocardial infarction.

Authors:  Karim D Mahmoud; Felix Zijlstra
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

5.  ST-elevation myocardial infarction, thrombus aspiration, and different invasive strategies. A TASTE trial substudy.

Authors:  Ole Fröbert; Fredrik Calais; Stefan K James; Bo Lagerqvist
Journal:  J Am Heart Assoc       Date:  2015-06-15       Impact factor: 5.501

Review 6.  Pathophysiology of coronary thrombus formation and adverse consequences of thrombus during PCI.

Authors:  Sundararajan Srikanth; John A Ambrose
Journal:  Curr Cardiol Rev       Date:  2012-08

7.  A novel model for evaluating thrombolytic therapy in dogs with ST-elevation myocardial infarction.

Authors:  Hong Zhang; Yong-Chun Cui; Yi Tian; Wei-Min Yuan; Jian-Zhong Yang; Peng Peng; Kai Li; Xiao-Peng Liu; Dong Zhang; Ai-Li Wu; Zhou Zhou; Yue Tang
Journal:  BMC Cardiovasc Disord       Date:  2016-01-25       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.